Anti-IL-17A [MM17F3]
Ab01266-1.1

ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
TargetIl17a
Overview
- SupplierAbsolute Antibody
- Product NameAnti-IL-17A [MM17F3]
- Delivery Days Customer7
- Application Supplier NoteThe specificity of this antibody has been confirmed in ELISA analysis (Uyttenhove et al, 2006). This antibody inhibits IL-17A-induced IL-6 production by a Cl1D fibroblastic cell line in vitro (Uyttenhove et al, 2006). This antibody has been shown to prevent experimental autoimmune encephalomyelitis (EAE) disease development in vivo (Uyttenhove et al, 2006), as well as protecting C57Bl/6 mice from myelin oligdendrocyte glycoprotein (MOG)-induced EAE (Uyttenhove et al, 2007). Additionally, administration of this antibody inhibits collagen-induced arthritis (CIA) in IFN-gamma receptor knockout mice (Kelchtermans et al, 2009).
- ApplicationsELISA, Neutralisation/Blocking
- Applications SupplierELISA; blocking; therapeutic
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDMM17F3
- Gene ID16171
- Target nameIl17a
- Target descriptioninterleukin 17A
- Target synonymsCtl; Ctla; Ctla8; Ctla-8; cytotoxic T-lymphocyte-associated antigen 8; Il; IL-; Il17; IL-17; IL-17A; interleukin-17A
- HostMouse
- IsotypeIgG1
- Protein IDQ62386
- Protein NameInterleukin-17A
- Reactivity SupplierMouse
- Reactivity Supplier NoteThis antibody was raised by immunising C57Bl/6 mice with IL-17A cross-linked to ovalbumin to generate a highly immunogenic complex.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203